The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1s,4s)-4-(6-amino-2-chloro-9H-purin-9-yl)-N-(1H-imidazol-2-yl)cyclohexanecarboxamide ID: ALA5094555
PubChem CID: 134214642
Max Phase: Preclinical
Molecular Formula: C15H17ClN8O
Molecular Weight: 360.81
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(Cl)nc2c1ncn2[C@H]1CC[C@@H](C(=O)Nc2ncc[nH]2)CC1
Standard InChI: InChI=1S/C15H17ClN8O/c16-14-21-11(17)10-12(22-14)24(7-20-10)9-3-1-8(2-4-9)13(25)23-15-18-5-6-19-15/h5-9H,1-4H2,(H2,17,21,22)(H2,18,19,23,25)/t8-,9+
Standard InChI Key: QKUXDTKTFLFIJR-DTORHVGOSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
27.5283 -21.9595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2380 -21.5501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2352 -20.7274 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5266 -20.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8203 -21.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8215 -20.7340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0453 -20.4805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5643 -21.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0434 -21.8017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5228 -19.5050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7897 -22.5785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9909 -22.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7365 -23.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2794 -24.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0804 -23.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3383 -23.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0228 -24.9018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2226 -25.0675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6790 -24.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5664 -25.5120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9464 -21.9576 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.8500 -23.6549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1445 -23.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5343 -23.7862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8628 -24.5344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
4 10 1 0
11 9 1 1
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 1 1
17 18 1 0
18 19 1 0
17 20 2 0
2 21 1 0
19 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.81Molecular Weight (Monoisotopic): 360.1214AlogP: 2.15#Rotatable Bonds: 3Polar Surface Area: 127.40Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.95CX Basic pKa: 3.70CX LogP: 1.62CX LogD: 1.61Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -0.98
References 1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P.. (2021) Identification of unprecedented ATP-competitive choline kinase inhibitors., 51 [PMID:34416377 ] [10.1016/j.bmcl.2021.128310 ]